← Back
Data updated: Mar 10, 2026
AXSOME
Neurology
AXSOME is a pharmaceutical company focused on Neurology. Key products include AUVELITY.
2022
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
AUVELITY 2025-11-05
Labeling
SYMBRAVO 2025-01-30
Type 4 - New Combination
AUVELITY 2024-05-07
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs Phase 3: 8 Phase 2: 1
Pipeline Strength Pro
Loading...